In polymerase chain reaction (PCR), bulk RNA sequencing, and Western blotting assays, the upregulation of MCT4 in cancer cells may be covered by other cells with high MCT4 expression, such as immune cells and vascular endothelial cells. Here, SLC16A3 is linked to cancer.